Bioinks
-
Humabiologics, an industry leader in providing human-derived biomaterials for regenerative medicine, founded by scientists and tissue industry experts to address the gap between the gift of donated human tissues and researchers, and Fisher Scientific, a global leader in life sciences, are partnering to serve researchers in academia and industry who…
Read More -
Rousselot, Darling Ingredients’ health brand, and the global leader in collagen-based solutions launched its GMP grade GelMA bioink. According to the company, X-Pure GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions. Good manufacturing practice (GMP) describes the minimum standard that a medicines…
Read More -
Rousselot, Darling Ingredients’ health brand and the world’s leader of collagen-based solutions, has partnered with the Terasaki Institute for Biomedical Innovation (TIBI), a California-based research institute focused on regenerative medicine. Through this strategic partnership, Rousselot and TIBI will collaborate on the development of gelatin-based therapies and their translation to the…
Read More -
Boston Micro Fabrication (BMF), one of the pioneers in microscale 3D printing systems, and UK-based 3D printing materials company 4D Biomaterials have jointly achieved the capability to print micro-scale geometries using 4Degra bioresorbable materials. This marks the first time a bioresorbable material has been printed using micro 3D printing and…
Read More -
In memory of Jemma Redmond My journey in this industry started over ten years ago as a young wide-eyed regenerative medicine master’s student at NUI Galway, that suddenly became an “extrusion 3D bioprinting maximalist and deep technology entrepreneur” during my bioengineering British Heart Foundation-funded Ph.D. research scholarship at Imperial College…
Read More -
Andrea GambiniNovember 3, 2021
Brinter launches multipurpose Brinter Core bioprinter
Finnish (Turku-based) bioprinting startup Brinter has launched its new entry-level model, Brinter Core. The multi-material 3D bioprinting solution is designed to be more portable and is half the cost of its predecessor, allowing more pharmaceutical companies, hospitals, universities, and research centers to access the technology under tight budget restrictions. Brinter…
Read More -
Davide SherNovember 1, 2021
Funakoshi to distribute Humabiologics bioinks in Japan
Humabiologics entered into a non-exclusive agreement with Funakoshi to respond to the growing demand of human-derived biomaterials and bioinks serving a broader life sciences customer base of industry partners and academic institutions in the Japanese market. Humabiologics develops and commercializes high-quality and affordable human-derived biomaterials for translational regenerative medicine applications…
Read More -
BICO, an expert bio convergence company, has been granted two patents relating to the regulation and control of temperatures in 3D Bioprinters. The first patent, US 11,046,001, was granted in the United States and relates to the temperature regulation of bioinks which allows for better cell viability during 3D bioprinting.…
Read More -
Jellagen, a biotech company developing a proprietary next-generation biomaterial, Collagen Type 0, entered a partnership with Copner Biotech, a pioneer in 3D bioprinting, after securing innovation funding of £123,724 from SMART Cymru. Professor Andrew Mearns Spragg, Founder and Chief Scientific Officer of Jellagen commented “We are absolutely delighted to partner…
Read More -
Davide SherSeptember 26, 2021
Humabiologics GMP hydrogels are now ISO 13485 certified
The Humabiologics human-derived hydrogels for regenerative medicine are now ISO 13485:2016 certified as well as GMP compliant for the manufacturing of human-derived biomaterials. The scope of the certificate covers the design, manufacture, and distribution of human biomaterials, components, and sub-assemblies for use in research and development, medical devices, pharmaceuticals, and…
Read More